Fig. 1
From: Adipose group 1 innate lymphoid cells promote adipose tissue fibrosis and diabetes in obesity
Adipose ILC1s correlate with the development of obesity and obese T2D. a Analysis of ILC1s by flow cytometry. b Absolute numbers (cells ml−1) of circulating ILC1s in control subjects (n = 36), obese subjects (n = 27), and obese T2D patients (n = 22). c Absolute numbers (cells mg−1) of adipose ILC1s in controls (n = 24), obese subjects (n = 21), and obese T2D patients (n = 20). d Correlation between adipose ILC1s numbers and circulating ILC1s (n = 65). e Numbers of circulating ILC1s before and at 3 months after bariatric surgery. f Correlation between reduction of circulating ILC1s and decrement of BMI levels in obese patients with 3-months follow-up (n = 36). g, h Correlations between decrement of fasting glucose levels and HbA1c levels with reduction of circulating ILC1s in obese T2D subgroup (n = 17). i–k Correlations between BMI, HOMA-IR, and Adipo-IR with adipose ILC1s (n = 65). **P < 0.01 (two-way ANOVA tests followed by Bonferroni post hoc test). Error bars indicate s.d. ILC innate lymphoid cells
